Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Riko Ikeda
Observed name:
Riko Maruyama
Institution:
Institute of Science Tokyo
Observed institutions:
Saitama Cancer Center,
Institute of Science Tokyo
ORCID:
0000-0002-5793-7895
Observed ORCID:
0000-0002-5793-7895
OpenAlex ID:
A5047861703
Late recurrence of late-onset large cell calcifying Sertoli tumor successfully managed by early surgical intervention
2022
·
Riko Ikeda
, Yoh Matsuoka
, et al.
·
Urology Case Reports
·
3
PDF
Treatment‐related neuroendocrine prostate cancer with BRCA2 germline mutation treated with olaparib
2023
·
Riko Ikeda
, Yoh Matsuoka
, et al.
·
IJU Case Reports
·
2
Quantitative Evaluation of Pharmacologic Synergy for Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle‐Invasive Bladder Cancer: A Copula‐Based Secondary Analysis
2026
·
Riko Ikeda
, Soichiro Yoshida
, et al.
·
International Journal of Urology
·
1
PDF
Oligometastatic Prostate and Bladder Cancer: An Integrative Narrative Review
2025
·
Wei Chen
, Soichiro Yoshida
, et al.
·
International Journal of Urology
·
1
PDF
Mixed Response to Nivolumab Among Different Metastatic Sites in Patients With Metastatic Renal Cell Carcinoma: Incidence and Clinical Implications
2026
·
Yudai Ishikawa
, Hajime Tanaka
, et al.
·
International Journal of Urology
Show more works
View as search
Works count:
5
Citation count:
7
H-index:
2
I10-index:
Year
Topic
Type